Skip to main content
Premium Trial:

Request an Annual Quote

LifeCodexx Receives CE Mark for qPCR-Based NIPT Analysis Software

NEW YORK (GenomeWeb) – Germany-based LifeCodexx said today it has received CE marking for analysis software for a new noninvasive prenatal test for fetal trisomy 21 that is based on methylation-specific quantitative PCR.

The software, PrenaTest BioIT, is now cleared for the analysis of data from both LifeCodexx's existing next-generation sequencing-based PrenaTest and from its new methylation-specific qPCR-based qNIPT assay.

The company has developed and validated qNIPT with about 2,500 maternal blood samples. In a blinded prospective validation study with almost 1,000 samples, qNIPT demonstrated 100 percent concordance with results from the existing PrenaTest. Also, qNIPT provided reliable results from blood samples with low fetal fraction down to 2.4 percent, showed cost efficiency, and had a rapid turnaround time, according to the firm.

"As our qNIPT is based on the most widely used platform within the molecular diagnostic space, this technology will offer the advantage of simplified integration into the lab routines of many laboratories around the world," said LifeCodexx CEO Michael Lutz in a statement.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.